Subanalysis of the Impact of OLmesartan on theprogression of coronary atherosclerosis: evaluation by IntraVascular UltraSound (OLIVUS) trial
Not Applicable
- Conditions
- Patients with stable angina pectoris and hypertension scheduled for PCI
- Registration Number
- JPRN-UMIN000008309
- Lead Sponsor
- Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
Patinets have complicated lesions (such as excessive tortuosity or calcified lesions, or lesions that could not be cross-sectioned using IVUS), chronic renal failure (serum creatinine >1.5), recent myocardial infarction (within 4 weeks), or poor ejection fraction (<25%); or if they were taking an angiotensin-converting enzyme (ACE) inhibitor or ARB.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method